← 產業報告目錄
Long-acting Reversible Contraceptives (LARCs) Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 138報告編號 APO-e29ad1f3a3
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Long-acting Reversible Contraceptives (LARCs) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Long-acting Reversible Contraceptives (LARCs) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Long-acting Reversible Contraceptives (LARCs) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Long-acting Reversible Contraceptives (LARCs) include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Long-acting Reversible Contraceptives (LARCs) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Long-acting Reversible Contraceptives (LARCs) Market by Company
AbbVie Allergan
ASPIVIX
Cooper Companies
Durbin
H & J Medical
HRA Pharma
Laboratoire 7 MED
Laboratoire CCD
OCON
Pregna
Prosan
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Yantai JiShengYaoXie
Bayer
Merck
Long-acting Reversible Contraceptives (LARCs) Segment by Type
Copper Intrauterine Devices
Hormonal Intrauterine Devices
Contraceptive Implants
Others
Long-acting Reversible Contraceptives (LARCs) Segment by Application
Age 20-24
Age 25-34
Age 35-44
Others
Long-acting Reversible Contraceptives (LARCs) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Long-acting Reversible Contraceptives (LARCs) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Long-acting Reversible Contraceptives (LARCs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032)
2.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032)
2.2.3 Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (2021-2032)
2.3 Long-acting Reversible Contraceptives (LARCs) by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Copper Intrauterine Devices
2.3.3 Hormonal Intrauterine Devices
2.3.4 Contraceptive Implants
2.3.5 Others
2.4 Long-acting Reversible Contraceptives (LARCs) by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Age 20-24
2.4.3 Age 25-34
2.4.4 Age 35-44
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales (k units) of Manufacturers (2021-2026)
3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue of Manufacturers (2021-2026)
3.4 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturers (2021-2026)
3.5 Global Long-acting Reversible Contraceptives (LARCs) Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application
3.8 Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Established Date
3.9 Global Long-acting Reversible Contraceptives (LARCs) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 AbbVie Allergan
4.1.1 AbbVie Allergan Company Information
4.1.2 AbbVie Allergan Business Overview
4.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.1.5 AbbVie Allergan Recent Developments
4.2 ASPIVIX
4.2.1 ASPIVIX Company Information
4.2.2 ASPIVIX Business Overview
4.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.2.5 ASPIVIX Recent Developments
4.3 Cooper Companies
4.3.1 Cooper Companies Company Information
4.3.2 Cooper Companies Business Overview
4.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.3.5 Cooper Companies Recent Developments
4.4 Durbin
4.4.1 Durbin Company Information
4.4.2 Durbin Business Overview
4.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.4.5 Durbin Recent Developments
4.5 H & J Medical
4.5.1 H & J Medical Company Information
4.5.2 H & J Medical Business Overview
4.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.5.5 H & J Medical Recent Developments
4.6 HRA Pharma
4.6.1 HRA Pharma Company Information
4.6.2 HRA Pharma Business Overview
4.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.6.5 HRA Pharma Recent Developments
4.7 Laboratoire 7 MED
4.7.1 Laboratoire 7 MED Company Information
4.7.2 Laboratoire 7 MED Business Overview
4.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.7.5 Laboratoire 7 MED Recent Developments
4.8 Laboratoire CCD
4.8.1 Laboratoire CCD Company Information
4.8.2 Laboratoire CCD Business Overview
4.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.8.5 Laboratoire CCD Recent Developments
4.9 OCON
4.9.1 OCON Company Information
4.9.2 OCON Business Overview
4.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.9.5 OCON Recent Developments
4.10 Pregna
4.10.1 Pregna Company Information
4.10.2 Pregna Business Overview
4.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.10.5 Pregna Recent Developments
4.11 Prosan
4.11.1 Prosan Company Information
4.11.2 Prosan Business Overview
4.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.11.5 Prosan Recent Developments
4.12 Shanghai Dahua Pharmaceuticals
4.12.1 Shanghai Dahua Pharmaceuticals Company Information
4.12.2 Shanghai Dahua Pharmaceuticals Business Overview
4.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
4.13 Williams Medical Supplies
4.13.1 Williams Medical Supplies Company Information
4.13.2 Williams Medical Supplies Business Overview
4.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.13.5 Williams Medical Supplies Recent Developments
4.14 Yantai JiShengYaoXie
4.14.1 Yantai JiShengYaoXie Company Information
4.14.2 Yantai JiShengYaoXie Business Overview
4.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.14.5 Yantai JiShengYaoXie Recent Developments
4.15 Bayer
4.15.1 Bayer Company Information
4.15.2 Bayer Business Overview
4.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.15.5 Bayer Recent Developments
4.16 Merck
4.16.1 Merck Company Information
4.16.2 Merck Business Overview
4.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
4.16.5 Merck Recent Developments
5 Global Long-acting Reversible Contraceptives (LARCs) Market Scenario by Region
5.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021-2032
5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021-2026
5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2027-2032
5.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021-2032
5.3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021-2026
5.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2027-2032
5.4 North America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
5.4.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
5.4.3 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
5.5.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
5.5.3 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
5.6.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
5.6.3 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
5.7.1 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
5.7.3 South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
5.8.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
5.8.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
6.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032) & (k units)
6.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032)
6.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
6.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032)
6.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2032)
7 Segment by Application
7.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
7.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032) & (k units)
7.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032)
7.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
7.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032)
7.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
8.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
8.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
8.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
9 Global Long-acting Reversible Contraceptives (LARCs) Analyzing Market Dynamics
9.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
9.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
9.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
9.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Long-acting Reversible Contraceptives (LARCs) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Long-acting Reversible Contraceptives (LARCs) Revenue of Manufacturers (2021-2026)
Table 9. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Long-acting Reversible Contraceptives (LARCs) Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Product Type & Application
Table 14. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Long-acting Reversible Contraceptives (LARCs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. AbbVie Allergan Company Information
Table 19. AbbVie Allergan Business Overview
Table 20. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 22. AbbVie Allergan Recent Developments
Table 23. ASPIVIX Company Information
Table 24. ASPIVIX Business Overview
Table 25. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 27. ASPIVIX Recent Developments
Table 28. Cooper Companies Company Information
Table 29. Cooper Companies Business Overview
Table 30. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 32. Cooper Companies Recent Developments
Table 33. Durbin Company Information
Table 34. Durbin Business Overview
Table 35. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 37. Durbin Recent Developments
Table 38. H & J Medical Company Information
Table 39. H & J Medical Business Overview
Table 40. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 42. H & J Medical Recent Developments
Table 43. HRA Pharma Company Information
Table 44. HRA Pharma Business Overview
Table 45. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 47. HRA Pharma Recent Developments
Table 48. Laboratoire 7 MED Company Information
Table 49. Laboratoire 7 MED Business Overview
Table 50. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 52. Laboratoire 7 MED Recent Developments
Table 53. Laboratoire CCD Company Information
Table 54. Laboratoire CCD Business Overview
Table 55. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 57. Laboratoire CCD Recent Developments
Table 58. OCON Company Information
Table 59. OCON Business Overview
Table 60. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 62. OCON Recent Developments
Table 63. Pregna Company Information
Table 64. Pregna Business Overview
Table 65. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 67. Pregna Recent Developments
Table 68. Prosan Company Information
Table 69. Prosan Business Overview
Table 70. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 72. Prosan Recent Developments
Table 73. Shanghai Dahua Pharmaceuticals Company Information
Table 74. Shanghai Dahua Pharmaceuticals Business Overview
Table 75. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 77. Shanghai Dahua Pharmaceuticals Recent Developments
Table 78. Williams Medical Supplies Company Information
Table 79. Williams Medical Supplies Business Overview
Table 80. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 82. Williams Medical Supplies Recent Developments
Table 83. Yantai JiShengYaoXie Company Information
Table 84. Yantai JiShengYaoXie Business Overview
Table 85. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 87. Yantai JiShengYaoXie Recent Developments
Table 88. Bayer Company Information
Table 89. Bayer Business Overview
Table 90. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 92. Bayer Recent Developments
Table 93. Merck Company Information
Table 94. Merck Business Overview
Table 95. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
Table 97. Merck Recent Developments
Table 98. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units)
Table 100. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2026)
Table 101. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (k units)
Table 102. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2027-2032)
Table 103. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2026)
Table 105. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2027-2032)
Table 107. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units)
Table 109. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units)
Table 110. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units)
Table 114. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units)
Table 115. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units)
Table 124. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units)
Table 125. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units)
Table 133. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units)
Table 134. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2026)
Table 135. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2027-2032)
Table 136. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2026)
Table 139. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2027-2032)
Table 140. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2021-2026) & (USD/unit)
Table 141. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2027-2032) & (USD/unit)
Table 142. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units)
Table 143. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units)
Table 144. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2026)
Table 145. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2027-2032)
Table 146. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2026)
Table 149. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2027-2032)
Table 150. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2021-2026) & (USD/unit)
Table 151. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Long-acting Reversible Contraceptives (LARCs) Distributors List
Table 155. Long-acting Reversible Contraceptives (LARCs) Customers List
Table 156. Long-acting Reversible Contraceptives (LARCs) Industry Trends
Table 157. Long-acting Reversible Contraceptives (LARCs) Industry Drivers
Table 158. Long-acting Reversible Contraceptives (LARCs) Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Long-acting Reversible Contraceptives (LARCs) Product Image
Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032) & (US$ Million)
Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units)
Figure 8. Global Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) & (2021-2032)
Figure 9. Copper Intrauterine Devices Product Image
Figure 10. Hormonal Intrauterine Devices Product Image
Figure 11. Contraceptive Implants Product Image
Figure 12. Others Product Image
Figure 13. Age 20-24 Product Image
Figure 14. Age 25-34 Product Image
Figure 15. Age 35-44 Product Image
Figure 16. Others Product Image
Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers in 2025
Figure 18. Global Manufacturers of Long-acting Reversible Contraceptives (LARCs), Manufacturing Sites & Headquarters
Figure 19. Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region in 2025
Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region in 2025
Figure 24. North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025
Figure 25. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032)
Figure 26. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032)
Figure 27. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025
Figure 31. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032)
Figure 32. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032)
Figure 33. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Spain Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Netherlands Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Switzerland Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Sweden Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Poland Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025
Figure 44. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032)
Figure 45. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032)
Figure 46. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025
Figure 55. South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032)
Figure 56. South America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032)
Figure 57. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Chile Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country in 2025
Figure 61. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032)
Figure 62. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2021-2032)
Figure 63. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Israel Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Türkiye Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. GCC Countries Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032)
Figure 69. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032)
Figure 70. Global Long-acting Reversible Contraceptives (LARCs) Price (USD/unit) by Type (2021-2032)
Figure 71. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032)
Figure 72. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032)
Figure 73. Global Long-acting Reversible Contraceptives (LARCs) Price (USD/unit) by Application (2021-2032)
Figure 74. Long-acting Reversible Contraceptives (LARCs) Value Chain
Figure 75. Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
Figure 76. Direct Comparison with Distribution Share
Figure 77. Distributors Profiles
Figure 78. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
提及公司
AbbVie AllerganASPIVIXCooper CompaniesDurbinH & J MedicalHRA PharmaLaboratoire 7 MEDLaboratoire CCDOCONPregnaProsanShanghai Dahua PharmaceuticalsWilliams Medical SuppliesYantai JiShengYaoXieBayerMerck
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們